NDC 83257-002 - OGIVRI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83257-002
- Package NDCs from labels
- 83257-002-11
- Manufacturer
- Biocon Biologics Inc. | Biocon Biologics Limited
- Effective date
- 2026-06-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OGIVRI - Biocon Biologics Inc. | Biocon Biologics Limited | Biocon Biologics Inc. | Biocon Biologics Limited | 2026-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Aurohealth LLC | d3c77f3f-57aa-4e2d-88aa-731cbb22af70 | 2026-04-23 | Warnings | G2M7P15E5P |
| Ontruzant | TRASTUZUMAB | Organon LLC | ce2a2492-85e3-4b0a-872a-047f44e4203d | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | P188ANX8CK |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | G2M7P15E5P |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | G2M7P15E5P |
| clear lax | POLYETHYLENE GLYCOL 3350 | Meijer Distribution Inc | 6464f12c-0883-46c5-943b-a84fe235588e | 2026-04-13 | Warnings | G2M7P15E5P |
| Trazimera | TRASTUZUMAB-QYYP | Pfizer Laboratories Div Pfizer Inc | b9c5e894-27d2-4245-a653-df986fed3c56 | 2026-04-10 | Boxed warning, Warnings, Adverse reactions | P188ANX8CK |
| equate clear lax | POLYETHYLENE GLYCOL 3350 | Wal-Mart Stores Inc | 56a507f3-0cd1-4f02-9dfd-de297ba4bc1f | 2026-03-27 | Warnings | G2M7P15E5P |
| foster and thrive clearlax | POLYETHYLENE GLYCOL 3350 | Strategic Sourcing Services LLC | 684e35cc-5a4f-458d-b5e7-e1933fea1139 | 2026-03-07 | Warnings | G2M7P15E5P |
| Walgreens Unscented Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | Walgreen Co. | 41eadb4f-2ca5-42a1-e063-6294a90ab4e2 | 2026-03-04 | Warnings | LKG8494WBH |
| ez2go Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Valley Medical Products, LLC | d64517d6-b0cc-4ba2-b260-e52faa8d4e78 | 2026-02-20 | Warnings | G2M7P15E5P |
| Topcare ClearLax | POLYETHYLENE GLYCOL 3350 | Topco Associates LLC | 03291fd3-7b64-4b79-ad84-e1b9b30a6b03 | 2026-02-19 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | American Health Packaging | 81374641-e54c-4b41-a3ad-49b19a097666 | 2026-02-18 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | GLENMARK THERAPEUTICS INC., USA | 5aba6bb1-d25d-4901-8e9c-4cd4a3a06471 | 2026-01-27 | Warnings | G2M7P15E5P |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals Inc. | 935f05da-3637-4a9e-843e-1f2ced5d1a74 | 2026-01-23 | Warnings | G2M7P15E5P |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | YYBA Corp | 48488531-5d04-4af6-e063-6294a90afe4b | 2026-01-13 | Warnings | G2M7P15E5P |
| L-Histidine High 7410 | L-HISTIDINE HIGH | Professional Complementary Health Formulas | 7eec7d23-236f-4770-9587-1bf602fd91c2 | 2026-01-08 | Warnings | 4QD397987E |
| GeriCare Sorbitol Solution | SORBITOL | GERI-CARE PHARMACEUTICALS, CORP | b4dd7a41-380e-d94b-e053-2a95a90ac34a | 2025-12-31 | Warnings | 506T60A25R |
| HERZUMA | TRASTUZUMAB | Cephalon, Inc. | ae71c003-883a-4cd8-ad50-e8cc9a54e971 | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | P188ANX8CK |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.